Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia : A population-based survey

• Published in: Journal of Cancer Policy
• Main Authors: Znaor, Ariana, Ryzhov, Anton, Losada, María Lasierra, Carvalho, Andre, Smelov, Vitaly, Barchuk, Anton, Valkov, Mikhail, Ten, Elena, Andreasyan, Diana, Zhizhilashvili, Saba, Dushimova, Zaure, Zhuikova, Lilia D., Egorova, Alla, Yaumenenka, Alesya, Djanklich, Sayde, Tril, Orest, Bray, Freddie, Corbex, Marilys
• Other Authors: Tampere University, Health Sciences
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2023
• Subjects: 3142 Public health care science; environmental and occupational health; 3122 Cancers; 3123 Gynaecology and paediatrics; Arkhangelsk
• Online Access: https://trepo.tuni.fi/handle/10024/151291; https://doi.org/10.1016/j.jcpo.2023.100436

Background: Eastern Europe and Central Asia (EECA) countries have higher cervical and breast cancer mortality rates and later stage at diagnosis compared with the rest of WHO European Region. The aim was to explore current early detection practices including “dispensarization” for breast and cervix cancer in the region. Methods: A questionnaire survey on early detection practices for breast and cervix cancer was sent to collaborators in 11 countries, differentiating services in the primary health setting, and population-based programs. Responses were received from Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, the Russian Federation (Arkhangelsk, Samara and Tomsk regions), Tajikistan, Ukraine, and Uzbekistan. Results: All countries but Georgia, Kyrgyzstan, and the Russian Federation had opportunistic screening by clinical breast exam within “dispensarization” program. Mammography screening programs, commonly starting from age 40, were introduced or piloted in eight of nine countries, organized at national oncology or screening centres in Armenia, Belarus and Georgia, and within primary care in others. Six countries had “dispensarization” program for cervix cancer, mostly starting from the age 18, with smears stained either by Romanowsky-Giemsa alone (Belarus, Tajikistan and Ukraine), or alternating with Papanicolaou (Kazakhstan and the Russian Federation). In parallel, screening programs using Papanicolaou or HPV test were introduced in seven countries and organized within primary care. Conclusion: Our study documents that parallel screening systems for both breast and cervix cancers, as well as departures from evidence-based practices are widespread across the EECA. Within the framework of the WHO Initiatives, existing opportunistic screening should be replaced by population-based programs that include quality assurance and control. Peer reviewed